New hope for Alzheimer's psychosis: drug targets troubling hallucinations
NCT ID NCT06887192
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 25 times
Summary
This study tests an experimental drug, ML-007C-MA, to see if it can reduce hallucinations and delusions in people with Alzheimer's disease. About 300 participants aged 55 to 90 will receive either the drug or a placebo. The goal is to improve quality of life by easing these distressing symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Site
RECRUITINGPhoenix, Arizona, 85004, United States
-
Clinical Site
RECRUITINGScottsdale, Arizona, 85253, United States
-
Clinical Site
RECRUITINGTucson, Arizona, 85704, United States
-
Clinical Site
RECRUITINGAnaheim, California, 92805, United States
-
Clinical Site
RECRUITINGOrange, California, 92866, United States
-
Clinical Site
RECRUITINGSan Diego, California, 92123, United States
-
Clinical Site
RECRUITINGBoca Raton, Florida, 33428, United States
-
Clinical Site
RECRUITINGDeerfield Beach, Florida, 33442, United States
-
Clinical Site
RECRUITINGDoral, Florida, 33122, United States
-
Clinical Site
RECRUITINGHomestead, Florida, 33033, United States
-
Clinical Site
RECRUITINGMiami, Florida, 33122, United States
-
Clinical Site
RECRUITINGMiami, Florida, 33155, United States
-
Clinical Site
RECRUITINGMiami, Florida, 33173, United States
-
Clinical Site
RECRUITINGMiami, Florida, 33186, United States
-
Clinical Site
RECRUITINGMiami Gardens, Florida, 33014, United States
-
Clinical Site
RECRUITINGMiami Gardens, Florida, 33104, United States
-
Clinical Site
RECRUITINGNaples, Florida, 34105, United States
-
Clinical Site
RECRUITINGOrlando, Florida, 32807, United States
-
Clinical Site
RECRUITINGWest Palm Beach, Florida, 33407, United States
-
Clinical Site
RECRUITINGLas Vegas, Nevada, 89121, United States
-
Clinical Site
RECRUITINGWest Long Branch, New Jersey, 07764, United States
-
Clinical Site
RECRUITINGIndependence, Ohio, 44131, United States
-
Clinical Site
NOT_YET_RECRUITINGBrampton, Ontario, L6W 2Z8, Canada
-
Clinical Site
RECRUITINGLondon, Ontario, N6A 5W9, Canada
-
Clinical Site
RECRUITINGToronto, Ontario, M4N 3M5, Canada
-
Clinical Site
RECRUITINGLévis, Quebec, G6V 0C9, Canada
Conditions
Explore the condition pages connected to this study.